These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7331693)

  • 1. [Molecular abnormalities of coagulation-fibrinolysis factors].
    Sakata Y; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1212-8. PubMed ID: 7331693
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis.
    Conard J; Horellou MH; Samama M
    Acta Chir Scand Suppl; 1988; 543():15-25. PubMed ID: 2973199
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital abnormalities related to coagulation and the fibrinolytic system in patients with vein thrombosis of the lower extremities].
    Murayama H; Manabe S; Matsuda M
    Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):450-5. PubMed ID: 3754931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver].
    Serov NA; Sukhanov VA; Podymova SD
    Klin Med (Mosk); 1991 Apr; 69(4):73-5. PubMed ID: 1865658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood coagulation studies in a family with congenital plasminogen abnormality--with a special relevance to the association of thrombotic tendency with abnormal plasminogen].
    Shinmyozu K; Maruyama Y; Osame M; Igata A
    Rinsho Ketsueki; 1986 Feb; 27(2):133-9. PubMed ID: 3723817
    [No Abstract]   [Full Text] [Related]  

  • 7. IgA nephritis associated with plasminogen abnormalities.
    Kitamoto Y; Nakayama M; Sakata Y; Taguchi H; Kuwahara K; Arima S; Ikezaki N; Nakano T; Kiyama S; Tomita M
    Clin Nephrol; 1990 Feb; 33(2):61-5. PubMed ID: 2311307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood clotting abnormalities in liver disease.
    Aledort LM
    Prog Liver Dis; 1976; 5():350-62. PubMed ID: 775547
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic abnormalities of the fibrinolytic system.
    Aoki N
    Prog Clin Biol Res; 1981; 72():229-47. PubMed ID: 7199719
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation and fibrinolysis following hemorrhage in the dog].
    Worowski K; Glowiński S
    Acta Physiol Pol; 1969; 20(4):655-62. PubMed ID: 5360631
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis: molecular mechanism and pathophysiological aspects.
    Lijnen HR
    Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Thoraxchir Vask Chir; 1970 Dec; 18(6):510-9. PubMed ID: 5275551
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorder of homeostasis of blood coagulation and fibrinolysis in patients with arterial hypotension].
    Aslanian NL; Zalinian LS
    Zh Eksp Klin Med; 1973; 13(6):61-5. PubMed ID: 4803635
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood coagulation in young patients with hypertensive disease].
    Andrushenko EV
    Vrach Delo; 1974 Nov; 0(11):35-7. PubMed ID: 4432467
    [No Abstract]   [Full Text] [Related]  

  • 15. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
    Moriau M
    Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fuctional changes of various blood coagulation parameters during surgery].
    Alánt O; Rubányi P
    Zentralbl Chir; 1974 Sep; 99(37):1164-71. PubMed ID: 4613065
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y
    Rinsho Byori; 1989 Mar; 37(3):256-60. PubMed ID: 2787424
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombotic tendency due to congenital disorders of coagulation or fibrinolysis (author's transl)].
    Sakata Y; Aoki N
    Rinsho Ketsueki; 1980 Jun; 21(6):714-22. PubMed ID: 7463730
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboelastography in liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1995; 21 Suppl 4():34-44. PubMed ID: 8747686
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on abnormal fibrinogen].
    Takamatsu J; Iwanaga S
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1203-11. PubMed ID: 7331692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.